Cost–Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting

被引：3
|
作者：
Bin Wu
Li Kun
Xiaoyan Liu
Ben He
机构：
[1] Shanghai Jiao Tong University,Clinical Outcomes and Economics Group, Department of pharmacy, Ren Ji Hospital, School of Medicine
[2] Center for ADR Monitoring of Linyi,Department of Cardiology, Ren Ji Hospital, School of Medicine
[3] Shanghai Jiao Tong University,undefined
来源：
Cardiovascular Drugs and Therapy | 2014年 / 28卷
关键词：
Cost-effectiveness; State-transition microsimulation model; Atrial fibrillation; Rivaroxaban; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 98
页数：11
相关论文
共 50 条
  • [21] Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
    Joris Kleintjens
    Xiao Li
    Steven Simoens
    Vincent Thijs
    Marnix Goethals
    Ernst R. Rietzschel
    Yumi Asukai
    Ömer Saka
    Thomas Evers
    Petra Faes
    Stefaan Vansieleghem
    Mimi De Ruyck
    PharmacoEconomics, 2013, 31 : 909 - 918
  • [22] Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
    Kleintjens, Joris
    Li, Xiao
    Simoens, Steven
    Thijs, Vincent
    Goethals, Marnix
    Rietzschel, Ernst R.
    Asukai, Yumi
    Saka, Omer
    Evers, Thomas
    Faes, Petra
    Vansieleghem, Stefaan
    De Ruyck, Mimi
    PHARMACOECONOMICS, 2013, 31 (10) : 909 - 918
  • [23] Who Gets Stroke Prevention? Stroke Prevention in Atrial Fibrillation Patients in the Inpatient Setting
    Gallagher, Robyn
    Roach, Kellie
    Sadler, Leonie
    Belshaw, Julie
    Kirkness, Ann
    Zhang, Ling
    Proctor, Ross
    Neubeck, Lis
    HEART LUNG AND CIRCULATION, 2015, 24 (05): : 488 - 494
  • [24] COST-EFFECTIVENESS OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN CHINA
    Wan, Y.
    Davies, G. M.
    Lu, Z. G.
    Chen, F.
    Chen, J.
    VALUE IN HEALTH, 2014, 17 (03) : A114 - A114
  • [25] Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
    Pletscher, Mark
    Plessow, Rafael
    Eichler, Klaus
    Wieser, Simon
    SWISS MEDICAL WEEKLY, 2013, 143
  • [26] Strategies for stroke prevention in atrial fibrillation
    Chung, MK
    Burkhardt, JD
    Klein, AL
    HEART RHYTHM, 2005, 2 (01) : 103 - 106
  • [27] Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting
    Shah, Maunank
    Johns, Benjamin
    Abimiku, Alash'le
    Walker, Damian G.
    AIDS, 2011, 25 (08) : 1093 - 1102
  • [28] The Cost-Effectiveness of Repeat HIV Testing During Pregnancy in a Resource-Limited Setting
    Kim, Lena H.
    Cohan, Deborah L.
    Sparks, Teresa N.
    Pilliod, Rachel A.
    Arinaitwe, Emmanuel
    Caughey, Aaron B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (02) : 195 - 200
  • [29] SETTING UP THE RIGHT SCENARIOS FOR COST-EFFECTIVENESS ANALYSIS: AN EXAMPLE WITH ANTICOAGULANTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS IN CHINA
    Wan, Y.
    Lu, Z. G.
    Chen, F.
    Chen, J.
    VALUE IN HEALTH, 2014, 17 (07) : A762 - A762
  • [30] A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
    Bruminhent, Jackrapong
    Bushyakanist, Asalaysa
    Kantachuvesiri, Surasak
    Kiertiburanakul, Sasisopin
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (09):
12345